TY - JOUR
T1 - Newly discovered neutral glycosphingolipids in Aureobasidin A-resistant Zygomycetes. Identification of a novel family of gala-series glycolipids with core Galα1-6Galβ1-6Galβ sequences
AU - Aoki, Kazuhiro
AU - Uchiyama, Ryosuke
AU - Yamauchi, Suguru
AU - Katayama, Takane
AU - Itonori, Saki
AU - Sugita, Mutsumi
AU - Hada, Noriyasu
AU - Yamada-Hada, Junko
AU - Takeda, Tadahiro
AU - Kumagai, Hidehiko
AU - Yamamoto, Kenji
PY - 2004/7/30
Y1 - 2004/7/30
N2 - We found for the first time that Zygomycetes species showed resistance to Aureobasidin A, an antifungal agent. A novel family of neutral glycosphingolipids (GSLs) was found in these fungi and isolated from Mucor hiemalis, which is a typical Zygomycetes species. Their structures were completely determined by compositional sugar, fatty acid, and sphingoid analyses, methylation analysis, matrix-assisted laser desorption ionisation lime-of-flight/mass spectrometry, and 1H NMR spectroscopy. They were as follows: Galβ1-6Galβ1-1Cer (CDS), Galα1-6Galβ1- 6Galβ1-1Cer (CTS), Galα1-6Galα1-6Galβ1-6Galβ1-1Cer (CTeS), and Galα1-6Galα1-6Galα1-6Galβ1-6Galβ1-1Cer (CPS). The ceramide moieties of these GSLs consist of 24:0,25:0, and 26:0 2-hydroxy acids as major fatty acids and 4-hydroxyoctadecasphinganine (phytosphingosine) as the sole sphingoid. However, the glycosylinositolphosphoceramide families that are the major GSLs components in fungi were not detected in Zygomycetes at all. This seems to be the reason that Aureobasidin A is not effective for Zygomycetes as an antifungal agent. Our results indicate that the biosynthetic pathway for GSLs in Zygomycetes is significantly different from those in other fungi and suggest that any inhibitor of this pathway may be effective for mucormycosis, which is a serious pathogenic disease for humans.
AB - We found for the first time that Zygomycetes species showed resistance to Aureobasidin A, an antifungal agent. A novel family of neutral glycosphingolipids (GSLs) was found in these fungi and isolated from Mucor hiemalis, which is a typical Zygomycetes species. Their structures were completely determined by compositional sugar, fatty acid, and sphingoid analyses, methylation analysis, matrix-assisted laser desorption ionisation lime-of-flight/mass spectrometry, and 1H NMR spectroscopy. They were as follows: Galβ1-6Galβ1-1Cer (CDS), Galα1-6Galβ1- 6Galβ1-1Cer (CTS), Galα1-6Galα1-6Galβ1-6Galβ1-1Cer (CTeS), and Galα1-6Galα1-6Galα1-6Galβ1-6Galβ1-1Cer (CPS). The ceramide moieties of these GSLs consist of 24:0,25:0, and 26:0 2-hydroxy acids as major fatty acids and 4-hydroxyoctadecasphinganine (phytosphingosine) as the sole sphingoid. However, the glycosylinositolphosphoceramide families that are the major GSLs components in fungi were not detected in Zygomycetes at all. This seems to be the reason that Aureobasidin A is not effective for Zygomycetes as an antifungal agent. Our results indicate that the biosynthetic pathway for GSLs in Zygomycetes is significantly different from those in other fungi and suggest that any inhibitor of this pathway may be effective for mucormycosis, which is a serious pathogenic disease for humans.
UR - http://www.scopus.com/inward/record.url?scp=3543011963&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=3543011963&partnerID=8YFLogxK
U2 - 10.1074/jbc.M312918200
DO - 10.1074/jbc.M312918200
M3 - Article
C2 - 15155728
AN - SCOPUS:3543011963
SN - 0021-9258
VL - 279
SP - 32028
EP - 32034
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 31
ER -